IPWSO 10th International Conference, Havana, Cuba

Tesomet shows promising results in reducing hyperphagia and weight in patients with Prader-Willi syndrome. Early data from a Phase 2a study highlights its potential as an effective, safe therapy addressing urgent unmet medical needs.